Hindustan Bio Sciences Q4 Results
- BSE: 532041
- NSE: -
- ISIN: INE597C01021
- Sector: Biotechnology & Drugs
BSE
8.99
0.10 (1.12%)
0.10 (1.12%)Volume17.01 K
Updated: Fri 10 Apr, 2026 | 15:22:14
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Hindustan Bio Sciences Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 0.28 | 0.32 | 584.75% | 0.35 | -18.66% |
| Total Revenue | 0.39 | 0.38 | 0.00% | 0.41 | -5.28% |
| Operating Income | 0.11 | 0.06 | 0.00% | 0.07 | 65.84% |
| Net Income | 0.11 | 0.08 | 0.00% | 0.04 | 148.57% |
| Selling/ General/ Admin Expenses Total | 0.03 | 0.05 | -7.67% | 0.03 | 14.03% |
| Other Operating Expenses Total | 0.02 | 0.02 | 89.29% | 0.09 | -81.39% |
| Net Income Before Taxes | 0.11 | 0.08 | 0.00% | 0.04 | 168.38% |
| Diluted Normalized EPS | 0.10 | 0.08 | 0.00% | 0.26 | -61.12% |